Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2008 2
2010 3
2011 2
2012 4
2013 5
2014 8
2015 6
2016 4
2017 5
2018 13
2019 8
2020 10
2021 16
2022 15
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum to "ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance" [Redox Biol. 43 (2021) 101977].
Sun Y, Qiao Y, Liu Y, Zhou J, Wang X, Zheng H, Xu Z, Zhang J, Zhou Y, Qian L, Zhang C, Lou H. Sun Y, et al. Among authors: zheng h. Redox Biol. 2024 Apr 24:103164. doi: 10.1016/j.redox.2024.103164. Online ahead of print. Redox Biol. 2024. PMID: 38664082 Free article. No abstract available.
Endovascular therapy in acute ischaemic stroke with large infarction with matched or mismatched clinical-radiological severities: a post-hoc analysis of the ANGEL-ASPECT trial.
Zheng L, Nie X, Wang M, Liu X, Duan W, Zhang Z, Liu J, Wei Y, Wen M, Yang Z, Leung TW, Ma G, Huo X, Pan Y, Nguyen TN, Leng X, Miao Z, Liu L; ANGEL-ASPECT Investigators. Zheng L, et al. EClinicalMedicine. 2024 Apr 12;72:102595. doi: 10.1016/j.eclinm.2024.102595. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38638180 Free PMC article.
The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial.
Cheng B, Li C, Li J, Gong L, Liang P, Chen Y, Zhan S, Xiong S, Zhong R, Liang H, Feng Y, Wang R, Wang H, Zheng H, Liu J, Zhou C, Shao W, Qiu Y, Sun J, Xie Z, Liang Z, Yang C, Cai X, Su C, Wang W, He J, Liang W. Cheng B, et al. Among authors: zheng h. Signal Transduct Target Ther. 2024 Apr 19;9(1):93. doi: 10.1038/s41392-024-01799-z. Signal Transduct Target Ther. 2024. PMID: 38637495 Free PMC article. Clinical Trial.
112 results